Krishnan Nandabalan, Director, 10% Owner at BioXcel Therapeutics, Inc. (BTAI), sold 60,000 shares at $15.00 ($900K) on 2022-11-10, disclosed to the SEC on 2022-11-14.
Open-market sale of $900k BTAI by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 27,450 | $412K | 45.8% |
| 2 | $15.00 | 32,550 | $488K | 54.3% |
| Total | $15.00 avg | 60,000 | $900K | 100% |
| Filing → |
| BTAI | SELL | 2021-06-29 | $29.2M | — | Filing → |
| BTAI | BUY | 2018-11-30 | $5K | — | Filing → |